These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 15139049

  • 1. beta-Catenin and p53 analyses of a breast carcinoma tissue microarray.
    Chung GG, Zerkowski MP, Ocal IT, Dolled-Filhart M, Kang JY, Psyrri A, Camp RL, Rimm DL.
    Cancer; 2004 May 15; 100(10):2084-92. PubMed ID: 15139049
    [Abstract] [Full Text] [Related]

  • 2. Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors.
    Tolgay Ocal I, Dolled-Filhart M, D'Aquila TG, Camp RL, Rimm DL.
    Cancer; 2003 Apr 15; 97(8):1841-8. PubMed ID: 12673709
    [Abstract] [Full Text] [Related]

  • 3. A survival-stratification model of human colorectal carcinomas with beta-catenin and p27kip1.
    Cheah PY, Choo PH, Yao J, Eu KW, Seow-Choen F.
    Cancer; 2002 Dec 15; 95(12):2479-86. PubMed ID: 12467060
    [Abstract] [Full Text] [Related]

  • 4. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer.
    Lim SC, Lee MS.
    Oncol Rep; 2002 Dec 15; 9(5):915-28. PubMed ID: 12168049
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours.
    Wong SC, Lo SF, Lee KC, Yam JW, Chan JK, Wendy Hsiao WL.
    J Pathol; 2002 Feb 15; 196(2):145-53. PubMed ID: 11793365
    [Abstract] [Full Text] [Related]

  • 7. Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features.
    Odajima T, Sasaki Y, Tanaka N, Kato-Mori Y, Asanuma H, Ikeda T, Satoh M, Hiratsuka H, Tokino T, Sawada N.
    Hum Pathol; 2005 Mar 15; 36(3):234-41. PubMed ID: 15791567
    [Abstract] [Full Text] [Related]

  • 8. Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosis.
    Vaziri SA, Krumroy LM, Elson P, Budd GT, Darlington G, Myles J, Tubbs RR, Casey G.
    Clin Cancer Res; 2001 Jul 15; 7(7):1937-45. PubMed ID: 11448907
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The significance of c-erbB-2 overexpression and p53 expression in patients with axillary lymph node--negative breast cancer: a tissue microarray study.
    Ko SS, Na YS, Yoon CS, Park JY, Kim HS, Hur MH, Lee HK, Chun YK, Kang SS, Park BW, Lee JH.
    Int J Surg Pathol; 2007 Apr 15; 15(2):98-109. PubMed ID: 17478762
    [Abstract] [Full Text] [Related]

  • 11. Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue.
    Bazas VM, Lukyanova NY, Lisovenko GS, Rozumiy DO, Potebnya GP.
    Exp Oncol; 2009 Sep 15; 31(3):182-4. PubMed ID: 19783961
    [Abstract] [Full Text] [Related]

  • 12. Coordinated expression of cyclin D1 and LEF-1/TCF transcription factor is restricted to a subset of hepatocellular carcinoma.
    Schmitt-Graeff A, Ertelt-Heitzmann V, Allgaier HP, Olschewski M, Nitschke R, Haxelmans S, Koelble K, Behrens J, Blum HE.
    Liver Int; 2005 Aug 15; 25(4):839-47. PubMed ID: 15998435
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of the co-expression of p53 and c-erbB-2 proteins in breast cancer.
    Nakopoulou LL, Alexiadou A, Theodoropoulos GE, Lazaris AC, Tzonou A, Keramopoulos A.
    J Pathol; 1996 May 15; 179(1):31-8. PubMed ID: 8691341
    [Abstract] [Full Text] [Related]

  • 14. Intracellular coexpression of epidermal growth factor receptor, Her-2/neu, and p21ras in human breast cancers: evidence for the existence of distinctive patterns of genetic evolution that are common to tumors from different patients.
    Shackney SE, Pollice AA, Smith CA, Janocko LE, Sweeney L, Brown KA, Singh SG, Gu L, Yakulis R, Lucke JF.
    Clin Cancer Res; 1998 Apr 15; 4(4):913-28. PubMed ID: 9563885
    [Abstract] [Full Text] [Related]

  • 15. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression.
    Park SS, Kim SW.
    Oncol Rep; 2007 Jul 15; 18(1):139-43. PubMed ID: 17549359
    [Abstract] [Full Text] [Related]

  • 16. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
    Pelosi G, Scarpa A, Puppa G, Veronesi G, Spaggiari L, Pasini F, Maisonneuve P, Iannucci A, Arrigoni G, Viale G.
    Cancer; 2005 Mar 15; 103(6):1154-64. PubMed ID: 15712207
    [Abstract] [Full Text] [Related]

  • 17. The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone.
    Cornfield DB, Palazzo JP, Schwartz GF, Goonewardene SA, Kovatich AJ, Chervoneva I, Hyslop T, Schwarting R.
    Cancer; 2004 Jun 01; 100(11):2317-27. PubMed ID: 15160334
    [Abstract] [Full Text] [Related]

  • 18. The multifunctional role of the immunohistochemical expression of MMP-7 in invasive breast cancer.
    Mylona E, Kapranou A, Mavrommatis J, Markaki S, Keramopoulos A, Nakopoulou L.
    APMIS; 2005 Apr 01; 113(4):246-55. PubMed ID: 15865605
    [Abstract] [Full Text] [Related]

  • 19. Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas.
    Kiss A, Wang NJ, Xie JP, Thorgeirsson SS.
    Clin Cancer Res; 1997 Jul 01; 3(7):1059-66. PubMed ID: 9815784
    [Abstract] [Full Text] [Related]

  • 20. beta-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck.
    Yu Z, Weinberger PM, Provost E, Haffty BG, Sasaki C, Joe J, Camp RL, Rimm DL, Psyrri A.
    Clin Cancer Res; 2005 Apr 01; 11(7):2471-7. PubMed ID: 15814622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.